A Comparison of Quantitative T2 Mapping on Cardiovascular Magnetic Resonance Imaging with Metaiodobenzylguanidine Scintigraphy and Left Ventricular Functional Recovery in Dilated Cardiomyopathy: A Retrospective Pilot Study

Internal Medicine
Tatsuro ItoKen-Ichi Hirata

Abstract

Metaiodobenzylguanidine (MIBG) scintigraphy is used to assess heart failure (HF) severity and to predict cardiac functional recovery. Cardiovascular magnetic resonance (CMR) imaging has recently been used to diagnosis HF. We evaluated CMR T2 mapping and MIBG scintigraphy in dilated cardiomyopathy (DCM) patients. Consecutively, 22 DCM patients [aged 56.8 ± 13.4 years; 6 women and 16 men; left ventricular ejection fraction (LVEF), 31.9 ± 10.7%] who underwent T2 mapping and MIBG scintigraphy were retrospectively evaluated. Echocardiography results were recorded at baseline and the 6-month follow-up. Patients with an increased LVEF ≥15% between the 2 measures were considered to be responders. We measured each patient's T2 values and MIBG indices [the heart-to-mediastinum ratio (H/M) in the early phase, H/M in the delayed phase, and the washout rate (WOR)] at baseline. We compared these values between the 12 responders and 10 non-responders. The mean T2 value for all patients was 64.5 ± 6.6 ms. The mean values of early H/M, delayed H/M, and WOR were 2.06 ± 0.25, 1.94 ± 0.35, and 43.5 ± 11.8%, respectively. The T2 values were found to correlate with MIBG indices (p<0.05 for all) and were lower in the responders than non-responders (6...Continue Reading

References

Oct 7, 1998·The American Journal of Cardiology·R Lapu-BulaJ L Vanoverschelde
Apr 13, 2000·The New England Journal of Medicine·G M FelkerE K Kasper
Dec 6, 2005·Journal of the American College of Cardiology·Satoru OhshimaMitsuhiro Yokota
Mar 28, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Yoshihisa MatsumuraYoshinori Doi
Nov 23, 2006·Journal of the American College of Cardiology·Ravi G AssomullDudley J Pennell
Apr 24, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Shohei Yamashina, Jun-ichi Yamazaki
Jan 18, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·James H CaldwellJohn R Stratton
Jun 21, 2008·Journal of the American College of Cardiology·Katherine C WuJoão A C Lima
Nov 8, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Denis AgostiniHein J Verberne
Nov 28, 2008·Heart and Vessels·Luisa De GennaroMatteo Di Biase
Jan 1, 2010·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Shivraman GiriOrlando P Simonetti
Mar 19, 2011·JACC. Cardiovascular Imaging·David VerhaertSubha V Raman
Nov 1, 2011·Circulation. Cardiovascular Imaging·Paaladinesh ThavendiranathanSubha V Raman
Mar 31, 2012·Clinical Cardiology·Michael JeserichAnnette Geibel
Apr 10, 2014·The International Journal of Cardiovascular Imaging·Tatsuya NishiiKazuro Sugimura
Aug 26, 2014·Current Cardiovascular Imaging Reports·Viviana MaestriniJames C Moon

❮ Previous
Next ❯

Citations

May 13, 2020·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·G J H SnelN H J Prakken

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.